Search Results - "Kusch Angelika"

Refine Results
  1. 1

    Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis by Hegner, Björn, Schaub, Theres, Catar, Rusan, Kusch, Angelika, Wagner, Philine, Essin, Kirill, Lange, Claudia, Riemekasten, Gabriela, Dragun, Duska

    Published in PloS one (07-04-2016)
    “…Obliterative vasculopathy and fibrosis are hallmarks of systemic sclerosis (SSc), a severe systemic autoimmune disease. Bone marrow-derived mesenchymal stromal…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Sex-Specific mTOR Signaling Determines Sexual Dimorphism in Myocardial Adaptation in Normotensive DOCA-Salt Model by Gürgen, Dennis, Kusch, Angelika, Klewitz, Robin, Hoff, Uwe, Catar, Rusan, Hegner, Björn, Kintscher, Ulrich, Luft, Friedrich C, Dragun, Duska

    Published in Hypertension (Dallas, Tex. 1979) (01-03-2013)
    “…The deoxycorticosterone acetate (DOCA)-salt mouse model exhibits adverse cardiac remodeling in male mice and cardiac protection in female mice, even when blood…”
    Get full text
    Journal Article
  5. 5

    17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling by Kusch, Angelika, Schmidt, Maria, Gürgen, Dennis, Postpieszala, Daniel, Catar, Rusan, Hegner, Björn, Davidson, Merci M, Mahmoodzadeh, Shokoufeh, Dragun, Duska

    Published in PloS one (2015)
    “…Adaptive cardiac remodeling is characterized by enhanced signaling of mTORC2 downstream kinase Akt. In females, 17ß-estradiol (E2), as well as Akt contribute…”
    Get full text
    Journal Article
  6. 6

    mTOR Regulates Vascular Smooth Muscle Cell Differentiation From Human Bone Marrow–Derived Mesenchymal Progenitors by Hegner, Björn, Lange, Maria, Kusch, Angelika, Essin, Kirill, Sezer, Orhan, Schulze-Lohoff, Eckhard, Luft, Friedrich C, Gollasch, Maik, Dragun, Duska

    “…OBJECTIVE—Vascular smooth muscle cells (VSMCs) and circulating mesenchymal progenitor cells (MSCs) with a VSMC phenotype contribute to neointima formation and…”
    Get full text
    Journal Article
  7. 7

    The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 by Gräler, Markus H., Grosse, Robert, Kusch, Angelika, Kremmer, Elisabeth, Gudermann, Thomas, Lipp, Martin

    Published in Journal of cellular biochemistry (01-06-2003)
    “…Sphingosine 1‐phosphate (S1P) receptors represent a novel subfamily of G‐protein‐coupled receptors binding S1P specifically and with high affinity. Although…”
    Get full text
    Journal Article
  8. 8

    Stat1 nuclear translocation by nucleolin upon monocyte differentiation by Jerke, Uwe, Tkachuk, Sergey, Kiyan, Julia, Stepanova, Victoria, Kusch, Angelika, Hinz, Michael, Dietz, Rainer, Haller, Hermann, Fuhrman, Bianca, Dumler, Inna

    Published in PloS one (14-12-2009)
    “…Members of the signal transducer and activator of transcription (Stat) family of transcription factors traverse the nuclear membrane through a specialized…”
    Get full text
    Journal Article
  9. 9

    The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1 by Kusch, Angelika, Tkachuk, Sergey, Tkachuk, Natalia, Patecki, Margret, Park, Joon-Keun, Dietz, Rainer, Haller, Hermann, Dumler, Inna

    Published in Cardiovascular research (01-07-2009)
    “…Aims Recent evidence suggests that the zonula occludens protein 2 (ZO-2) might have additional cellular functions, beyond regulation of paracellular…”
    Get full text
    Journal Article
  10. 10

    Urokinase Stimulates Human Vascular Smooth Muscle Cell Migration via a Phosphatidylinositol 3-Kinase-Tyk2 Interaction by Kusch, Angelika, Tkachuk, Sergey, Haller, Hermann, Dietz, Rainer, Gulba, Dietrich C., Lipp, Martin, Dumler, Inna

    Published in The Journal of biological chemistry (15-12-2000)
    “…Janus kinases Jak1 and Tyk2 play an important role in urokinase-type plasminogen activator (uPA)-dependent signaling. We have recently demonstrated that both…”
    Get full text
    Journal Article
  11. 11

    Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via β2-arrestin link to mTOR pathway by Catar, Rusan Ali, Wischnewski, Oskar, Chen, Lei, Heidecke, Harald, Rutz, Claudia, Schülein, Ralf, Dragun, Duska, Philippe, Aurélie, Kusch, Angelika

    Published in Kidney international (01-03-2022)
    “…Functional non-HLA antibodies (antibodies to non-human leukocyte antigens) targeting the G protein-coupled receptors angiotensin II type 1 receptor (AT1R) and…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection by Dragun, Duska, Catar, Rusan, Kusch, Angelika, Heidecke, Harald, Philippe, Aurélie

    Published in Human immunology (01-12-2012)
    “…Abstract Antibody-mediated mechanisms directed against non-HLA related targets may exert negative impact on allograft function and survival. Angiotensin type 1…”
    Get full text
    Journal Article
  15. 15

    Sex-specific dimorphism in cellular stress response upon mTOR inhibition revealed by podocyte specific RNA sequencing by Guergen, Dennis, Kusch, Angelika, Stottmeister, Christin, Al-Diab, Ola, Grahammer, Florian, Huber, Tobias B, Rajewski, Nikolaus, Dragun, Duska

    Published in Transplantation (01-07-2018)
    “…Why some kidney transplant patients treated with mTOR inhibitors develop proteinuria and majority of recipients of other solid organs improve their kidney…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Real-time monitoring of hypertrophy in HL-1 cardiomyocytes by impedance measurements reveals different modes of growth by Bloch, Laura, Ndongson-Dongmo, Bernadin, Kusch, Angelika, Dragun, Duska, Heller, Regine, Huber, Otmar

    Published in Cytotechnology (Dordrecht) (01-10-2016)
    “…Hypertrophic growth is a response of the heart to increased mechanical load or physiological stress. Thereby, cardiomyocytes grow in length and/or width to…”
    Get full text
    Journal Article
  18. 18

    17β-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling by Kusch, Angelika, Schmidt, Maria, Gürgen, Dennis, Postpieszala, Daniel, Rusan Catar, Hegner, Björn, Davidson, Merci M, Mahmoodzadeh, Shokoufeh, Dragun, Duska

    Published in PloS one (01-04-2015)
    “…Adaptive cardiac remodeling is characterized by enhanced signaling of mTORC2 downstream kinase Akt. In females, 17β-estradiol (E2), as well as Akt contribute…”
    Get full text
    Journal Article
  19. 19

    Abstract 442: Cardiomyocyte Specific mTORC1 Deletion Precipitates Interstitial Fibrosis, Heart Failure And Loss Of Female Cardio Protection by Guergen, Dennis, Kusch, Angelika, Kauz, Nelli, Catar, Rusan A, Brink, Marijke, Dragun, Duska

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2014)
    “…Abstract only Mechanistic target of rapamycin (mTOR) kinase operates in two functionally and structurally distinct multiprotein complexes mTORC1 and mTORC2…”
    Get full text
    Journal Article
  20. 20

    Abstract 270: mTORC1 is Essential for Cardiomyocyte Homeostasis and Female Sex Related Cardioprotection by Guergen, Dennis B, Beiner, Nelli, Catar, Rusan, Mielke, Thorsten, Busch, Hauke, Boerries, Melanie, Dengjel, Joern, Brink, Marijke, Grahammer, Florian, Huber, Tobias B, Kusch, Angelika, Dragun, Duska

    Published in Circulation research (22-07-2016)
    “…Abstract only Mechanistic target of rapamycin (mTOR) kinase operates in two functionally and structurally distinct protein complexes mTORC1 and mTORC2. Raptor…”
    Get full text
    Journal Article